1921
Volume 93, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

We report the elimination of transmission from the Central Endemic Zone (CEZ) of onchocerciasis in Guatemala, the largest focus of this disease in the Americas and the first to be discovered in this hemisphere by Rodolfo Robles Valverde in 1915. Mass drug administration (MDA) with ivermectin was launched in 1988, with semiannual MDA coverage reaching at least 85% of the eligible population in > 95% of treatment rounds during the 12-year period, 2000–2011. Serial parasitological testing to monitor MDA impact in sentinel villages showed a decrease in microfilaria skin prevalence from 70% to 0%, and polymerase chain reaction (PCR)-based entomological assessments of the principal vector s.l. showed transmission interruption by 2007. These assessments, together with a 2010 serological survey in children 9–69 months of age that showed Ov16 IgG4 antibody prevalence to be < 0.1%, meeting World Health Organization (WHO) guidelines for stopping MDA, and treatment was halted after 2011. After 3 years an entomological assessment showed no evidence of vector infection or recrudescence of transmission. In 2015, 100 years after the discovery of its presence, the Ministry of Health of Guatemala declared onchocerciasis transmission as having been eliminated from the CEZ.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0364
2015-12-09
2017-11-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/6/1295.html?itemId=/content/journals/10.4269/ajtmh.15-0364&mimeType=html&fmt=ahah

References

  1. Cupp EW, Sauerbrey M, Richards FO, , 2011. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan®) monotherapy. Acta Trop Suppl 120 (Suppl 1): S100S108.[Crossref]
  2. Richards FO, Miri E, Meredith S, Guderian R, Sauerbrey M, Remme H, Packard R, Ndiaye JM, , 1998. Onchocerciasis. Bull World Health Organ 76 (Suppl 2): 147149.
  3. Zimmerman PA, Katholi CR, Wooten MC, Lang-Unnasch N, Unnasch TR, , 1994. Recent evolutionary history of American Onchocerca volvulus, based on analysis of a tandemly repeated DNA sequence family. Mol Biol Evol 11: 384392.
  4. Anonymous, 2013. Progress toward elimination of onchocerciasis in the Americas. MMWR 87: 404407.
  5. Porter CH, Collins RC, , 1988. Seasonality of adult black flies and Onchocerca volvulus transmission in Guatemala. Am J Trop Med Hyg 38: 153167.
  6. Yamagata Y, Suzuki T, Garcia Manzo GA, , 1986. Geographical distribution of the prevalence of nodules of Onchocerca volvulus in Guatemala over the last four decades. Trop Med Parasitol 37: 2834.
  7. Robles R, Calderón V, , 1917. Enfermedad nueva en Guatemala. Guatemala: Revista de la Juventud Médica, año XVIII, tomo XVII. 8: 9116, 177.
  8. Robles R, , 1919. Onchocercose humaine au Guatemala produisant la cecite´ et “l'erysipe´ le du littoral” (Erisipela de la costa). Bull Soc Pathol Exot 12: 442460.
  9. Ochoa JO, Castro JC, Barrios VM, Juarez EL, Tada I, , 1997. Successful control of onchocerciasis vectors in San Vicente Pacaya, Guatemala, 1984–1989. Ann Trop Med Parasitol 91: 471479.[Crossref]
  10. Richards FO, Klein R, Zea-Flores R, Gonzáles-Peralta C, Castro J, Zea-Flores G, , 1995. Knowledge, attitudes, and perceptions during a community-level ivermectin distribution campaign in Guatemala. Health Policy Plan 10: 404414.[Crossref]
  11. Anonymous, 2001. Certification of Elimination of Human Onchocerciasis: Criteria and Procedures, Guidelines. Geneva, Switzerland: WHO WHO/CDS/CPE/CEE.18.b
  12. Collins RC, Gonzales-Peralta C, Castro J, Zea-Flores G, Cupp M, Richards FO, Cupp EW, , 1992. Ivermectin: reduction in prevalence and infection intensity with Onchocerca volvulus following biannual treatments in five Guatemalan communities. Am J Trop Med Hyg 47: 156169.
  13. Cupp EW, Ochoa JO, Collins RC, Cupp MS, Gonzales-Peralta C, Castro J, Zea-Flores G, , 1992. The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg 47: 170180.
  14. Sauerbrey MS, , 2008. The Onchocerciasis Program for the Americas (OEPA). Ann Trop Med Parasitol 102 (Suppl 1): S25S29.[Crossref]
  15. Blanks J, Richards FO, Beltran F, Collins RC, Alvarez E, Zea-Flores G, Bauler B, Cedillos R, Heisler M, Brandling-Bennett D, Baldwin W, Bayona M, Klein R, Jacox M, , 1998. The Onchocerciasis Elimination Program of the Americas: a history of partnership. Rev Panam Salud Publica 3: 367374.[Crossref]
  16. Program Coordinating Committee, OEPA Staff, 2012. Guide to detecting a potential recrudescence of onchocerciasis during the post treatment surveillance period: the American paradigm. Res Rep Trop Med 3: 2133.
  17. Brandling-Bennett AD, Anderson J, Fuglsang H, Collins RC, , 1981. Onchocerciasis in Guatemala. Epidemiology in fincas with various intensities of infection. Am J Trop Med Hyg 30: 970981.
  18. Winthrop K, Proaño R, Oliva O, Arana B, Mendoza C, Dominguez A, Amann J, Punkosdy G, Blanco C, Klein R, Sauerbrey M, Richards FO, , 2006. The reliability of anterior segment lesions as indicators of onchocercal eye disease in Guatemala. Am J Trop Med Hyg 75: 10581062.
  19. Lindblade KA, Arana B, Zea-Flores G, Rizzo N, Porter CH, Dominguez A, Cruz-Ortiz N, Unnasch TR, Punkosdy GA, Richards J, Sauerbrey M, Castro J, Catú E, Oliva O, Richards FO, , 2007. Elimination of Onchocerca volvulus transmission in the Santa Rosa Focus of Guatemala. Am J Trop Med Hyg 77: 334341.
  20. Rodrıguez-Perez MA, Katholi CR, Hassan HK, Unnasch TR, , 2006. Large scale entomologic assessment of Onchocerca volvulus transmission by poolscreen PCR in Mexico. Am J Trop Med Hyg 74: 10261033.
  21. Collins RC, , 1979. Onchocerciasis transmission potentials of four species of Guatemalan Simuliidae. Am J Trop Med Hyg 28: 7275.
  22. Lobos E, Weiss N, Karam M, Taylor HR, Ottesen EA, Nutman TB, , 1991. An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science 251: 16031605.[Crossref]
  23. Oguttu D, Byamukama E, Katholi CR, Habomugisha P, Nahabwe C, Ngabirano M, Hassan HK, Lakwo T, Katabarwa M, Richards FO, Unnasch TR, , 2014. Serosurveillance to monitor onchocerciasis elimination: the Ugandan experience. Am J Trop Med Hyg 90: 339345.[Crossref]
  24. Richards FO, David B, Hippolyte F, , 2000. Using GIS to target onchocerciasis control activities in Guatemala. , eds. Geographical Targeting for Poverty Alleviation: Methodology and Applications. Washington, DC: The World Bank Regional and Sectoral Studies, 235257.
  25. Katholi CR, Toe L, Merriweather A, Unnasch TR, , 1995. Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies. J Infect Dis 172: 14141417.[Crossref]
  26. Unnasch TR, Meredith S, , 1996. The use of degenerate primers in conjunction with strain and species oligonucleotides to classify Onchocerca volvulus . Methods Mol Biol 50: 293303.
  27. Wikipedia, 2015. Rodolfo Robles. Available at: http://wikiguate.com.gt/rodolfo-robles/. Accessed March 13, 2015.
  28. Rodrıguez-Perez MA, Domınguez-Vazquez A, Unnasch TR, Hassan HK, Arredondo-Jimenez JI, Orozco-Algarra ME, Rodríguez-Morales KB, Rodríguez-Luna IC, Prado-Velasco FG, , 2013. Interruption of transmission of Onchocerca volvulus in the southern Chiapas Focus, Mexico. PLoS Negl Trop Dis 7: e2133.[Crossref]
  29. Convit J, Schuler H, Borges R, Olivero V, Domínguez-Vázquez A, Frontado H, Grillet ME, , 2013. Interruption of Onchocerca volvulus transmission in northern Venezuela. Parasit Vectors 6: 289. Available at: http://www.parasitesandvectors.com/content/6/1/289.[Crossref]
  30. Anonymous, 2013. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification by WHO of elimination of transmission in Colombia. Wkly Epidemiol Rec 88: 381383.
  31. Anonymous, 2014. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: Ecuador's progress towards verification of elimination. Wkly Epidemiol Rec 89: 401408.
  32. Gonzales RJ, Cruz-Ortiz N, Rizzo N, Richards J, Zea-Flores G, Domínguez A, Sauerbrey M, Catú E, Orlando O, Richards FO, Lindblade KA, , 2009. Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala. PLoS Negl Trop Dis 3: e404.[Crossref]
  33. Cruz-Ortiz N, Gonzalez RJ, Lindblade KA, Richards F, Sauerbrey M, Dominguez A, Zea-Flores G, Olivia O, Catú E, Rizzo N, , 2012. Elimination of Onchocerca volvulus transmission in the Huehuetenango Focus of Guatemala. J Parasitol Res 2012: 638429.[Crossref]
  34. Cupp EW, Ochoa O, Collins RC, Ramberg F, Zea-Flores G, , 1989. The effect of multiple ivermectin treatments on infection of Simulium ochraceum with Onchocerca volvulus . Am J Trop Med Hyg 40: 501506.
  35. Cupp EW, Cupp MS, , 2005. Impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am J Trop Med Hyg 73: 11591161.
  36. Cupp EW, Duke BO, Mackenzie CD, Guzmán JR, Vieira JC, Mendez-Galvan J, Castro J, Richards FO, Sauerbrey M, Dominguez A, Eversole RR, Cupp MS, , 2004. The effects of long-term community level treatment with ivermectin on adult Onchocerca volvulus in Latin America. Am J Trop Med Hyg 71: 602607.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0364
Loading
/content/journals/10.4269/ajtmh.15-0364
Loading

Data & Media loading...

  • Received : 15 May 2015
  • Accepted : 17 Jul 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error